Ophthalmologic Baseline Characteristics and 2-Year Ophthalmologic Safety Profile of Pramipexole IR Compared with Ropinirole IR in Patients with Early Parkinson’s Disease

Background. Parkinson’s disease (PD) progressively affects dopaminergic neurotransmission and may affect retinal dopaminergic functions and structures. Objective. This 2-year randomized, open-label, parallel-group, flexible-dose study, NCT00144300, evaluated ophthalmologic safety profiles of immedia...

Full description

Bibliographic Details

Published in:	Parkinson's Disease
Main Authors:	William Seiple, Danna Jennings, Richard B. Rosen, Leona Borchert, Lee Canale, Nora Fagan, Mark Forrest Gordon
Format:	Article
Language:	English
Published:	Wiley 2016-01-01
Online Access:	http://dx.doi.org/10.1155/2016/8298503